Joel Muse, Jr

Title: Innovations of Joel Muse, Jr. in Pharmaceutical Compositions

Introduction

Joel Muse, Jr. is an accomplished inventor based in Annapolis, MD (US). He has made significant contributions to the field of pharmaceuticals, particularly through his innovative use of ethyl lactate as an excipient in pharmaceutical compositions. His work has the potential to enhance the solubility and effectiveness of biologically active compounds.

Latest Patents

Joel Muse, Jr. holds a patent for the "Use of ethyl lactate as an excipient for pharmaceutical compositions." This invention is based on the unexpected discovery that ethyl lactate can serve as an emulsifying and dispersing excipient for various biologically active compounds without compromising their pharmacological activity. Ethyl lactate has proven to be an effective agent for solubilizing compounds that are typically difficult to dissolve in conventional excipients. The operability of this invention relies on ensuring that the ethyl lactate is free of peroxide compounds, which can be achieved through various methods such as hydrogenation or distillation. The patent emphasizes the importance of maintaining a peroxide level of less than 10 ppm for the ethyl lactate to be viable as an excipient.

Career Highlights

Joel Muse, Jr. is associated with Archer Daniels Midland Company, where he applies his expertise in the development of pharmaceutical compositions. His innovative approach to using ethyl lactate has positioned him as a key figure in enhancing the effectiveness of drug formulations.

Collaborations

[This section has been skipped due to space constraints.]

Conclusion

Joel Muse, Jr.'s contributions to the pharmaceutical industry through his patent on ethyl lactate exemplify the importance of innovation in enhancing drug formulations. His work continues to pave the way for advancements in pharmaceutical compositions.